drugset / Trial / NCT02729207

Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain

NCT02729207

Phase 2 Terminated 6 enrolled Teikoku Seiyaku Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The safety and the efficacy of the Esflurbiprofen Hydrogel Patch will be assessed in comparing with placebo in the treatment of acute pain due to ankle sprain

Timeline

Start
2016-07
Primary completion
2016-12-21
Completion
2016-12-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Esflurbiprofen Small molecule 1.5 %

Indications

No indication recorded.